Abstract
Serum immunoglobulin levels and peripheral blood lymphocyte subsets were determined in 25 epileptic children treated with anticonvulsant drugs [carbamazepine (CBZ) or sodium valproate (VPA)], 17 untreated patients and 18 healthy subjects.
The treated and untreated patients did not differ significantly from the controls with respect to the mean IgA, IgG, IgM values or lymphocyte subsets. The patients on carbamazepine had lower serum concentrations of IgG (though not significantly lower) than the untreated patients and children on valproate.
OKT8 subset, in absolute terms and as a percentage of total lymphocytes, was significantly higher in generalized than in partial epilepsy, but this was probably due to the antiepileptic treatment.
We found a sex difference in serum immunoglobulins (Ig M, IgG) in the epileptic group.
Our data do not seem to argue for major changes in immune status related to clinical type of epilepsy or to VPA or CBZ treatment.
Sommario
Sono stati determinati i livelli di immunoglobuline sieriche e delle sottopopolazioni linfocitarie di 25 bambini epilettici trattati con farmaci anticonvulsivanti (Carbamazepina o Valproato di sodio), 17 pazienti senza terapia e 18 soggetti sani. Il gruppo di pazienti non trattati ed il gruppo dei trattati non differivano in modo significativo dai controlli per quanto riguarda i principali valori di IgA, IgG, IgM e delle sottopopolazioni linfocitarie.
La Carbamazepina agiva sulla concentrazione sierica di IgG (più bassa anche se in modo non significativo) respetto ai pazienti senza terapia ed ai bambini trattati con Valproato. Gli OKT8, sia in percentuale che in valore assoluto dei linfociti totali, erano più alti in modo significativo nelle forme di epilessia generalizzata rispetto alle forme parziali, ma questo risultato dipendeva probabilmente dalla terapia anticonvulsivante. Abbiamo rilevato una differenza fra maschi e femmine nelle concentrazioni di immunoglobuline sieriche (IgG, IgM) nel gruppo dei pazienti. I nostri dati non sembrano comunque avvalorare l'ipotesi dell'esistenza di alterazioni rilevanti nell'assetto immunologico in relazione al tipo clinico di epilessia ed al trattamento con CBZ o con VPA.
Similar content being viewed by others
References
Aarli J.A.:Changes in serum immunoglobulin levels during Phenytoin treatment of epilepsy. Acta Neurol. Scand. 54:423–430; 1976
Aarli J.A. andFontana A.:Immunological aspects of Epilepsy. Epilepsia 17:283–291; 1976
Bardana E.J., Gauborel J.D., Davies G.H. et al.:Effects of Phenytoin on man's immunity: evaluation of changes in serum immunoglobulins, complement and antinuclear antibody. Am. J. Med. 74:289–295; 1983
Bassanini M., Baez A. andSotelo J.:Immunoglobulins in Epilepsy. J. Neurol. Sci. 56:275–281; 1982
Boyum A.:Isolation of Leucocytes from Human Blood. Further Observations. Scand. J. Clin. Lab. Invest. Suppl. 97:31–50; 1968
Commission on Classification and Terminology of the ILAE: proposal for Revised Classification of Epilepsies and Epileptic Syndromes. Epilepsia 30: 389–399; 1989
De Domenico P., Musolino R., Gallitto G. et al.:Alterazioni immunologiche in corso di trattamento cronico con anticonvulsivanti. Riv. It. Biol. Med. 5:236–238; 1985.
Dreifuss F.E., Martines-Lage M., Roger J. et al:Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 26:268–278; 1985
Eeg-Olofsson O., Prchal J.F. andAndermann F.:Abnormalities of T-Lymphocyte subsets in epileptic children. Acta Neurol. Scand. 72:140–144; 1985
Eeg-Olofsson O., Safwenberg J., Wigertz A.:HLA and epilepsy: an investigation of different types of epilepsy in children and their families. Epilepsia 23:27–34; 1982
Eeg-Olofsson O., Janjua N.A., Andermann F. et al.:Immunological and genetic studies in primary generalized corticoreticular epilepsy. Acta Neurol. Scand. 74:425–431; 1986
Eeg-Olofsson O., Osterland C.K., Guttman R.D. et al.:Immunological studies in focal epilepsy. Acta Neurol. Scand. 78:358–368; 1988.
Fontana A., Joller H., Skvaril F. et al.:Immunological abnormalities and HLA antigen frequencies in IgA deficient patients with epilepsy. J. Neurol. Neurosurg. Psychiatry 41:593–597; 1978
Gilhus N.E., Strandjord R.E., andAarli J.A.:The effect of Carbamazepine on serum immunoglobulin concentrations. Acta Neurol. Scand. 66:172–179; 1982
Gilhus N.E., Strandjord R.E. andAarli J.A.:Respiratory disease in patients with epilepsy on single-drug therapy with Carbamazepine or Phenobarbital. Eur. Neurol. 21:284–188; 1982
Gilhus N.E. andLea T.:Carbamazepine: effect on IgG subclasses in Epileptic Patients. Epilepsia 29:317–320; 1988
Hafez M., Nagaty M. andSaied E.:HLA antigens and idiopathic epilepsy. Epilepsia 26:15–18; 1985
Hofman F.M., Billing R.J., Parker J.W. et al.:Cytoplasmatic as opposed to surface Ia antigens expressed on human peripheral blood lymphocytes and monocytes. Clin. Exp. Immunol. 49:355–363; 1982
Joubert P.H., Aucamp A.K., Potgieter et al.:Epilepsy and IgG deficiency. The effect of Sodium Valproate. S. Afr. Med. J. 52:642–644; 1977
Kanoh T., Uchine H.:Immunodeficiency and epilepsy. Lancet 1:860–1; 1976
Masi M., Paolucci P., Perocco P. et al.:Immunosuppression by Phenytoin.Lancet 1:860;1976
Minev M., Martinova F. andBelopitova L.:On the association of the HLA system with epilepsy in children. Epilepsia 29:74–76; 1987
Musolino R., Natali M., Gallitto G. et al.:The effect of chronic N-Didropylacetamide (“Depamide”) treatment on plasmatic immunoglobulins of epileptic patients. Acta Neurol. 35:115–120; 1980
Ruff M.E., Pincus G.L., Sampson H.A.:Phenytoin-Induced IgA depression. Am. J. Dis. Child. 141:858–861; 1987
Seager J., Wilson J., Jamison D.L. et al.:IgA deficiency, epilepsy and phenytoin treatment. Lancet 2:632–635; 1975
Smith D.T., Hamilton M.J., Biros M.H. et al.:Salivary and plasma IgA of seizure subjects receiving Phenytoin. Epilepsia 20:17–23; 1979
Sorrel T.C., Forbes I.J., Burness F.R. et al.:Depression of immunological functions in patients treated with phenytoin sodium. Lancet 2:1233–1235; 1971
Strandjord R.E., Johannesen S.J. andAarli J.A.:Serum concentration of immunoglobulins in patients with epilepsy treated with carbamazepine. Acta Neurol Scand 61, 260–268, 1980.
Tartara A., Verri A.P., Nespoli L. et al.:Immunological findings in epileptic and febrile convulsion patients before and under treatment. Eur. Neurol. 20:306–311; 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lenti, C., Masserini, C., Peruzzi, C. et al. Effects of carbamazepine and valproate on immunological assessment in young epileptic patients. Ital J Neuro Sci 12, 87–91 (1991). https://doi.org/10.1007/BF02337619
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02337619